SARS-CoV-2 vaccines in patients with SLE
W Tang, AD Askanase, L Khalili… - Lupus Science & Medicine, 2021 - lupus.bmj.com
W Tang, AD Askanase, L Khalili, JT Merrill
Lupus Science & Medicine, 2021•lupus.bmj.comAs the Moderna (mRNA-1273) and Pfizer/BioNTech (BNT162b2) vaccines become
available to patients with autoimmune diseases and SLE, practitioners will have to inform
them about the safety and efficacy of these vaccines. Here we discuss the challenges of
applying vaccine data to patients with autoimmune diseases and the evidence available in
the literature that may help in the decision process.
available to patients with autoimmune diseases and SLE, practitioners will have to inform
them about the safety and efficacy of these vaccines. Here we discuss the challenges of
applying vaccine data to patients with autoimmune diseases and the evidence available in
the literature that may help in the decision process.
As the Moderna (mRNA-1273) and Pfizer/BioNTech (BNT162b2) vaccines become available to patients with autoimmune diseases and SLE, practitioners will have to inform them about the safety and efficacy of these vaccines. Here we discuss the challenges of applying vaccine data to patients with autoimmune diseases and the evidence available in the literature that may help in the decision process.
lupus.bmj.com
